immatics Appoints Dr Rainer Kramer as CBO

News   Apr 12, 2012

 
immatics Appoints Dr Rainer Kramer as CBO
 
 
 

RELATED ARTICLES

Being Born During a Flu Pandemic May Increase Your Risk of Death During Another Flu Pandemic

News

While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, researchers are calling for more attention to exceptions to that rule.

READ MORE

Glythera Appoints Chief Scientific Officer and Strengthens SAB

News

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates. Dr Jon Roffey appointed to Scientific Advisory Board.

READ MORE

New Treatment Target for Melanoma

News

Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE